Body weight changes with protease inhibitor treatment in undernourished HIV-infected patients-Reference-Cited by-同舟云学术

Body weight changes with protease inhibitor treatment in undernourished HIV-infected patients

Published:1999-06 Issue:6 Volume:15 Page:453-457
ISSN:0899-9007
Container-title:Nutrition
language:en
Short-container-title:Nutrition

Author:

Schwenk Achim,Kremer Gisela,Cornely Oliver,Diehl Volker,Fätkenheuer Gerd,Salzberger Bernd

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism

Reference30 articles.

1. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection;Mellors;Ann Intern Med,1997

2. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic milliliter or less;Hammer;N Engl J Med,1997

3. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy;Gulick;N Engl J Med,1997

4. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents;MMWR,1998

5. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection;Palella;N Engl J Med,1998

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In situ metabolic flux analysis to quantify the liver metabolic response to experimental burn injury;Biotechnology and Bioengineering;2010-12-04

2. Longitudinal Anthropometric Patterns Among HIV-Infected and HIV-Uninfected Women;JAIDS Journal of Acquired Immune Deficiency Syndromes;2008-03-01

3. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy;HIV Medicine;2006-07

4. ESPEN Guidelines on Enteral Nutrition: Wasting in HIV and other chronic infectious diseases;Clinical Nutrition;2006-04

5. Changes in Weight and Lean Body Mass during Highly Active Antiretroviral Therapy;Clinical Infectious Diseases;2004-10-15